Infections caused by azithromycin-susceptible microorganisms: ENT infections (bacterial pharyngitis/tonsillitis, sinusitis acute otitis media); respiratory tract infections (bacterial bronchitis, community acquired pneumonia);  skin and soft tissue infections: chronic migrant erythema (early Lyme disease), erysipelas, impetigo, secondary pyodermatoses; sexually transmitted diseases: uncomplicated urethritis/cervicitis; gastric and duodenal infections due to Helicobacter pylori, as a part of combined therapy.

Infections caused by azithromycin-susceptible microorganisms: ENT infections (bacterial pharyngitis/tonsillitis, sinusitis acute otitis media). Respiratory tract infections (bacterial bronchitis, community acquired pneumonia). Skin and soft tissue infections: chronic migrant erythema (early Lyme disease), erysipelas, impetigo, secondary pyodermatoses. Sexually transmitted diseases: uncomplicated urethritis/cervicitis.

Infections caused by microorganisms sensitive to azithromycin: ENT infections (bacterial pharyngitis / tonsillitis, sinusitis, otitis media), respiratory tract infections (bacterial bronchitis, community-acquired pneumonia), skin and soft tissue infections (erythema migrans, the initial phase of Lyme disease), erysipelas, impetigo, secondary pyoderma.

Infections caused by microorganisms sensitive to azithromycin: ENT infections (bacterial pharyngitis / tonsillitis, sinusitis, otitis media), respiratory tract infections (bacterial bronchitis, community-acquired pneumonia), skin and soft tissue infections (erythema migrans, the initial phase of Lyme disease), erysipelas, impetigo, secondary pyoderma.

Infections caused by sensitive microorganisms: infections of the respiratory tract (sore throat, pneumonia, suppurative pleurisy, diphtheria, scarlet fever, actinomycosis of the lung); infections of the urogenital system (cystitis, syphilis, gonorrhea, colpitis, endocervicitis, endometritis, adnexitis, salpingo-oophoritis); infections of the organ of vision: conjunctivitis, blepharitis, dacryocystitis; purulent infections of the skin and soft tissues; bacterial endocarditis, septicemia; osteomyelitis; wound infections; mug; anthrax; meningitis; peritonitis; infections of the biliary tract.

Diseases due to microorganisms susceptible to the drug: Curative treatment for anthrax, necrobacillosis, pasteurellosis, pneumonia, mastitis, metritis, wound infections, septicemia, phlegmones; actinomycosis, blackleg and streptococcal septicemia of cattle, sheep, goats, fibrous and catarrhal pneumonia of horses; streptococcosis, staphylococcosis of foxes, arctic foxes, minks and dogs, swine erysipelas.

To reduce the symptoms of inflammatory dermatoses sensitive to glucocorticosteroid therapy, such as eczema (atopic, nummular), contact dermatitis, seborrhea dermatitis, atopic dermatitis, photo dermatitis , exfoliated dermatitis, stasis-dermatitis, radiation dermatitis, intertriginous dermatitis, psoriasis, anogenital and aged itching.

Treatment of dermatitis sensitive to strong glucocorticoid therapy such as psoriasis; the initial treatment of severe atopic eczema.